This website uses cookies to enhance your browsing experience, improve site performance, and gather analytics. By selecting 'Accept,' you consent to these cookies as described in our Privacy Policy.

GMP Drink for PKU Study

Sponsored by Nutricia UK Ltd

About this trial

Last updated 6 years ago

Study ID

GMP2016

Status

Completed

Type

Interventional

Phase

N/A

Placebo

No

Accepting

18-75 Years
3+ Years
All
All

Not accepting

Not accepting
Healthy Volunteers

Trial Timing

Ended 6 years ago

What is this trial about?

This study will evaluate the safety, gastrointestinal (GI) tolerance, acceptability and compliance of a Glycomacropeptide-based protein substitute for patients with Phenylketonuria (PKU).

What are the participation requirements?

Yes

Inclusion Criteria

- Male or female

- Over 3 years of age

- Diagnosed with classical or variant type phenylketonuria

- Have been compliant in taking at least one amino acid-based, Phe-free protein substitute, providing at least 20g protein equivalents, for at least 1 month prior to trial commencement

- Have a prescribed daily Phe allowance

- Written informed consent from patient, or from parent / carer if applicable

No

Exclusion Criteria

- Currently prescribed Sapropterin or similar tetrahydrobiopterin based medication

- Pregnant or lactating

- Requiring parenteral nutrition

- Major hepatic or renal dysfunction

- Participation in other studies within 1 month prior to entry of this study

- Allergy to any of the study product ingredients, including milk protein or soya

- Investigator concern around willingness/ability of patient or parent/carer to comply with protocol requirements